期刊文献+

携带Bcl-xl基因的重组慢病毒的制备和鉴定

Construction and identification of a recombinant lentivirus containing Bcl-xl
下载PDF
导出
摘要 目的制备携带Bcl-xl基因的重组慢病毒,并鉴定其感染细胞有效性。方法从本所以前构建的重组质粒pAAV-Bcl-xl获得Bcl-xl基因的编码序列,将其置换掉慢病毒质粒pSin-EF2-SOX2-Pur中的SOX2基因编码序列,从而得到重组慢病毒质粒pSin-EF2-Bcl-xl-Pur。然后利用这一质粒包装制备了携带Bcl-xl基因的重组慢病毒颗粒,用其感染细胞后用Western blot和流式检测仪分析了感染前后细胞中Bcl-xl基因的表达情况。结果感染后细胞中Bcl-xl蛋白的表达水平显著高于感染前。结论携带Bcl-xl基因的重组慢病毒颗粒包装成功,能高效感染细胞,为后续的遗传改造树突细胞打下了基础。 Objective To construct a recombinant lentivirus containing Bcl-xl gene,and to detect its infection capability. Methods Bcl-xl-encoded sequence was obtained from our previously constructed plasmid pAAV-Bcl-xl,and used to substitute the SOX2 sequence in a lentiviral plasmid pSin-EF2-SOX2-Pur to construct a lentiviral plasmid pSin-EF2-Bcl-xl-Pur. The recombinant lentivirus containing Bcl-xl was assembled,and used to infect 293FT cells. Western blot and FACS analysis were used to detect Bcl-xl expression in infected cells. Results The results indicate that the Bcl-xl expression level in the infected cells are significantly higher than that in the control cells. Conclusion The recombinant lentivirus containing Bcl-xl was successfully constructed,which laid a foundation for using Bcl-xl to genetically modify dendritic cells.
出处 《分子诊断与治疗杂志》 2010年第2期87-90,共4页 Journal of Molecular Diagnostics and Therapy
基金 国家高技术研究发展计划863课题(2006AA02A102) 国家重点基础研究发展规划973课题(2007CB948103和2007CB947901)
关键词 BCL-XL基因 重组慢病毒 树突细胞 Bcl-xl gene Recombinant lentivirus Dendritic cells
  • 相关文献

参考文献12

  • 1Cheng E H,Levine B,Boise L H,et al.Bax-independent inhibition of apoptosis by Bcl-xL[J].Nature,1996,379:554.
  • 2Eastman A,Rigas J R.Modulation of apoptosis signaling pathways and cell cycle regulation[J].Semin Oncol,1999,26(5 Suppl 16):7-16.
  • 3Vander Heiden M G,Thompson C B.Bcl-2 proteins:regulators of apoptosis or of mitochondrial homeostasis[J].Nat Cell Biol,1999,1:E209-E216.
  • 4Lotem J,Sachs L.Control of apoptosis in hematopoiesis and leukemia by cytokines,tumor suppressor and oncogenes[J].Leukemia,1996,10:925-931.
  • 5Fang W,Weintraub B C,Dunlap B,et al.Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by cional anergy and receptor editing[J].Immunity,1998,9:35-45.
  • 6Shurin M R.Dendritic cells presenting tumor antigen[J].Cancer Immunol Immunother,1996,43:158-164.
  • 7Stene M A,Babajanians M,Bhuta S,et al.Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin[J].J Invest Dermatol,1988,91:125-128.
  • 8Pirtskhalaishvili G,Shurin G V,Gambotto A,et al.Transduetion of dendritic cells with Bcl-xl increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice[J].J Immunol,2000,165:1956-1964.
  • 9Naldini L,Blomer U,Gallay P,et al.In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector[J].Science,1996,272:263-267.
  • 10Amado R G,Chen I S.Lentiviral vectors-the promise of gene therapy within reach[J].Science,1999,285:674-676.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部